MACURE PHARMA ApS: Financial statements 2015
CVR: 35234748
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
MACURE PHARMA ApS (CVR 35234748) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 680,373 and a net result of DKK 406,623 compared with DKK 66,464 the year before. That is an increase of 217.7% compared with the year before. Equity in the 2015 report amounted to DKK 823,374. The solvency ratio was 7.2%.
- Gross Profit
- DKK 680,373
- Profit/Loss
- DKK 406,623
- Equity
- DKK 823,374
- Total Assets
- DKK 11,392,214
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 680 t. | 407 t. | 823 t. | - |
| 2014 | - | 214 t. | 66 t. | 417 t. | - |
How creditworthy is MACURE PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
MACURE PHARMA ApS has published its annual report for 2014. Gross profit came to DKK 214,151, and the net result was DKK 66,464.
As of January 1, 2015, Din Revisor Frederiksberg P/S Godkendte Revisorer has been appointed auditor of MACURE PHARMA ApS.
As of January 1, 2015, Bogføring Danmark ApS has stepped down as auditor of MACURE PHARMA ApS.
About MACURE PHARMA ApS
MACURE PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mads Renlef Henningsen and Lars Mark Poulsen. The company is owned by Nest Egg ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. Equity in the 2025 report amounted to DKK 18,033,649.